The oxysterol receptor GPR183 was found to be a negative regulator of type I IFN in human monocytes where gene expression of IRF1, IRF5 and IRF7 is upregulated in type 2 diabetic patients who are TB-positive, thus corresponding to the down regulation of GPR183. The gene discussed is GPR183; the disease is tuberculosis.